Hussman Strategic Advisors Inc. Takes Position in Nutex Health Inc. $NUTX

Hussman Strategic Advisors Inc. bought a new stake in Nutex Health Inc. (NASDAQ:NUTX) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,000 shares of the company’s stock, valued at approximately $3,457,000. Nutex Health comprises approximately 0.8% of Hussman Strategic Advisors Inc.’s investment portfolio, making the stock its 12th largest position. Hussman Strategic Advisors Inc. owned about 0.30% of Nutex Health at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the third quarter valued at about $30,000. BNP Paribas Financial Markets raised its holdings in shares of Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. SG Americas Securities LLC purchased a new stake in shares of Nutex Health in the fourth quarter valued at about $150,000. Vestcor Inc purchased a new stake in shares of Nutex Health in the third quarter valued at about $111,000. Finally, New York State Common Retirement Fund purchased a new stake in shares of Nutex Health in the second quarter valued at about $137,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Stock Performance

NASDAQ NUTX opened at $139.57 on Friday. Nutex Health Inc. has a 52-week low of $77.21 and a 52-week high of $193.07. The company has a 50-day simple moving average of $102.21 and a 200 day simple moving average of $126.46. The company has a debt-to-equity ratio of 0.70, a quick ratio of 3.39 and a current ratio of 3.41. The company has a market capitalization of $972.80 million, a PE ratio of 10.79 and a beta of 0.25.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 24.13%. The business had revenue of $216.49 million during the quarter, compared to the consensus estimate of $227.80 million.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on NUTX shares. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Friday, March 27th. Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Saturday, March 7th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

More Nutex Health News

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Very large EPS beat and jump in net income — Nutex reported diluted EPS of $6.52 (well above consensus) and net income rose sharply year‑over‑year, which drove immediate investor enthusiasm. PR News Release
• Positive Sentiment: Stronger liquidity and cash flow — cash and equivalents grew materially and operating cash flow improved, giving the company flexibility for growth or debt management. This supports the bullish take despite near‑term margin noise. Quiver Quant
• Positive Sentiment: Growth plan: three hospital openings and internalized development — management plans to open three hospitals in H2 2026 and shift to in‑house development with build costs ~$20M–$30M each, signaling controlled expansion and potential margin upside over time. Seeking Alpha
• Positive Sentiment: Insider and institutional buying — recent insider purchases and several institutions adding shares suggest confidence from management and some larger investors. That tends to support the stock on positive headlines. Quiver Quant – Insider/Institutional Notes
• Neutral Sentiment: Mixed margin and profit signals — operating profit improved year‑over‑year even as gross profit contracted substantially; that makes the quarter mixed: better operating control but cost‑of‑sales pressures remain. Quiver Quant
• Negative Sentiment: Revenue missed analyst expectations — total revenue (~$216.5M) fell short of consensus, which raises questions about near‑term top‑line momentum. MarketBeat / Earnings Summary
• Negative Sentiment: Gross margin contraction and rising cost of sales — cost of sales increased materially, pulling down gross profit; if those trends persist, they could pressure margins before any benefits from new hospitals or in‑house builds are realized. Quiver Quant

Nutex Health Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.